Brad Hively Oncology Institute, Inc. (TOI) insider trading activity

Brad Hively is Director of Oncology Institute, Inc.. Currently has a direct ownership of 675,809 shares of TOI, which is worth approximately $1.62 Million. The most recent transaction as insider was on Mar 26, 2025, when has been sold 9,056 shares (Common Stock) at a price of $1.04 per share, resulting in proceeds of $9,418. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 676K

1.36% 3M change

5.33% 12M change

Total Value Held $1.62 Million

Brad Hively Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 26 2025	BUY Open market or private purchase	$9,418 $1.04 p/Share	9,056 Added 1.32%	675,809 Common Stock
Dec 02 2024	BUY Open market or private purchase	$7,500 $0.15 p/Share	50,000 Added 6.98%	666,753 Common Stock
Nov 26 2024	BUY Open market or private purchase	$42,500 $0.17 p/Share	250,000 Added 28.84%	616,753 Common Stock
Nov 22 2024	BUY Grant, award, or other acquisition	-	44,000 Added 5.76%	720,203 Common Stock
Nov 12 2024	SELL Other acquisition or disposition	-	353,450 Reduced 49.08%	366,753 Common Stock
Jun 17 2024	SELL Sale (or disposition) back to the issuer	$8,335 $0.46 p/Share	18,121 Reduced 2.61%	676,203 Common Stock
May 22 2024	SELL Sale (or disposition) back to the issuer	$11,325 $0.58 p/Share	19,526 Reduced 2.74%	694,324 Common Stock
Dec 26 2023	BUY Grant, award, or other acquisition	-	42,652 Added 5.64%	713,850 Common Stock
Nov 21 2023	SELL Sale (or disposition) back to the issuer	$56,648 $2.19 p/Share	25,867 Reduced 3.71%	671,198 Common Stock
Nov 17 2023	SELL Open market or private sale	$56,000 $2.24 p/Share	25,000 Reduced 3.46%	697,065 Common Stock
Nov 17 2023	BUY Exercise of conversion of derivative security	$21,250 $0.85 p/Share	25,000 Added 3.35%	722,065 Common Stock
Nov 14 2023	SELL Sale (or disposition) back to the issuer	$64,809 $2.39 p/Share	27,117 Reduced 3.74%	697,065 Common Stock
Nov 13 2023	SELL Open market or private sale	$118,440 $2.52 p/Share	47,000 Reduced 6.09%	724,182 Common Stock
Nov 13 2023	BUY Exercise of conversion of derivative security	$39,950 $0.85 p/Share	47,000 Added 5.74%	771,182 Common Stock
Mar 17 2023	BUY Grant, award, or other acquisition	-	168,512 Added 18.88%	724,182 Common Stock
Nov 17 2022	BUY Grant, award, or other acquisition	-	103,469 Added 15.7%	555,670 Common Stock
Nov 15 2022	SELL Sale (or disposition) back to the issuer	$19,727 $2.03 p/Share	9,718 Reduced 2.1%	452,201 Common Stock
Mar 21 2022	BUY Grant, award, or other acquisition	-	108,469 Added 19.02%	461,919 Common Stock
Jan 12 2021	BUY Grant, award, or other acquisition	-	353,450 Added 62.5%	212,070 Common Stock

Brad Hively

Director

Cerritos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Value

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI

Account